According to the latest data from the Hong Kong Stock Exchange, on January 6, JPMorgan increased its holding in Hengrui Pharma (01276) by 1,127,828 shares, with a transaction price of approximately HK$74.6126 per share, amounting to a total consideration of around HK$84.15 million. Following this acquisition, JPMorgan's total shareholding has risen to approximately 19.194 million shares, representing a latest持股比例 of 7.43%.
- Like
- Comment
- Favorite
JPMorgan Boosts Stake in Hengrui Pharma (01276) by Approximately 1.13 Million Shares at HK$74.61 Per Share
Stock News01-09
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Like
Report
Login to post
No comments yet